
The treatment uses peptides designed to retrain the immune system to tolerate peanuts

More than 186,000 men are diagnosed each year with mHSPC globally

Mezigdomide improves progression-free survival in patients with relapsed or refractory multiple myeloma

Ecopipam could become the first new FDA-approved treatment for paediatric Tourette syndrome in over ten years

This is the first and only at-home subcutaneous treatment option for this disease

Globally, around 150 to 200 out of every million people have myasthenia gravis

Over one million people are diagnosed globally each year and around 30% of stage 3 patients relapse within five years

This new option for patients allows for as few as six maintenance injections per year

The mortality rates of UCDs exceeds 25%, with no curative treatment available for newborns

This type of cancer is the most common one diagnosed in teenagers

The draft guidance specifically discusses genome editing and RNA-based therapies

Rare diseases are defined as conditions affecting fewer than 200,000 people in the US or fewer than five in 10,000 individuals in the European Union